default author photo

Frank Heppner

Charité - Universitätsmedizin Berlin - Institute for Neuropathology

Charitéplatz 1

Berlin, 10117

Germany

SCHOLARLY PAPERS

2

DOWNLOADS

1,205

TOTAL CITATIONS

22

Scholarly Papers (2)

1.

Defining Microglial States and Nomenclature: A Roadmap to 2030

Number of pages: 44 Posted: 23 Mar 2022
University of Lausanne - Department of Biomedical Sciences, Achucarro Basque Center for Neuroscience, Broad Institute of Harvard and MIT - Stanley Center for Psychiatric Research, University of Victoria, University of Zurich - Institute of Neuropathology, Oregon Health and Science University - Department of Molecular Microbiology and Immunology, Weizmann Institute of Science - Department of Immunology, University of Montpellier - Institut de Génomique Fonctionnelle (IGF), University of Leipzig - Institute of Anatomy, University of Pennsylvania - Children's Hospital of Philadelphia, University of Pennsylvania - Children's Hospital of Philadelphia, École Normale Supérieure (ENS), AbbVie Deutschland GmbH & Co. KG - Neuroscience Discovery, Duke University - Department of Psychology and Neuroscience, University of California, Irvine - Center for the Neurobiology of Learning and Memory, University of Groningen - Department of Biomedical Sciences of Cells & Systems, University of Lisbon - Research Institute for Medicines (iMed.ULisboa), Hasselt University - Biomedical Research Institute, University of Cambridge - Department of Biochemistry, Harvard University - Ann Romney Center for Neurologic Diseases, University of California, Riverside (UCR) - Center for Glial-Neuronal Interactions, Fisiología e Inmunología - Unidad de Histología Medica, Washington University in St. Louis - Department of Pathology and Immunology, University of Oxford - James and Lillian Martin Centre for Stem Cell Research, Trinity College (Dublin) - School of Biochemistry and Immunology, Cleveland Clinic - Department of Neurosciences, Columbia University - Center for Translational and Systems Neuroimmunology, University College London - Bart de Strooper, Hungarian Academy of Sciences (HAS) - “Momentum” Laboratory of Neuroimmunology, University of Groningen - Department of Biomedical Sciences of Cells & Systems, Mayo Clinic - Department of Neurology, Autonomous University of Barcelona - Institut de Neurociències and Departament de Bioquímica, École Normale Supérieure - PSL Research University - Institute of Biology of the Ecole Normale Supérieure (IBENS), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), University of California, San Diego (UCSD) - Department of Cellular & Molecular Medicine, Ludwig Maximilian University of Munich (LMU) - Institute for Stroke and Dementia Research, University of Southampton - School of Biological Sciences, Fisiología e Inmunología - Unidad de Histología Medica, University of Oxford - Sir William Dunn School of Pathology, The University of Sydney - Ken Parker Brain Tumour Research Laboratories, Brain and Mind Centre, The University of Manchester - Lydia Becker Institute of Immunology and Inflammation, University of Paris - INSERM, University of Zurich - Institute of Experimental Immunology, Washington University in St. Louis - School of Medicine, Universite du Luxembourg - Luxembourg Centre for Systems Biomedicine, University of Bonn - Department of Neurodegenerative Disease and Gerontopsychiatry, Charité - Universitätsmedizin Berlin - Institute for Neuropathology, University College London - UK Dementia Research Institute, Weizmann Institute of Science - Department of Immunology, Helmholtz Association of German Research Centres - Max Delbrück Center for Molecular Medicine, University of Virginia - Department of Neuroscience, University of Tokyo - Laboratory of Chemical Pharmacology, Salk Institute for Biological Studies - Molecular Neurobiology Laboratory, Trinity College (Dublin) - Institute of Neuroscience, University of Rochester - Department of Neuroscience, King’s College London - Wolfson Centre for Age-Related Diseases, University of Eastern Finland - A.I. Virtanen Institute for Molecular Sciences, University of Antwerp - Department of Biomedical Sciences, Humanitas University - Department of Biomedical Sciences, UK Dementia Research Institute, University of Edinburgh - MRC Centre for Reproductive Health, University of California, San Francisco (UCSF), University of California, Berkeley - Howard Hughes Medical Institute (HHMI), Discovery Pharmacology - Roche Innovation Center Zurich, University of Bordeaux - Neurocentre Magendie, German Center for Neurodegenerative Diseases (DZNE), Vilnius University - VU LSC-EMBL Partnership for Genome Editing Technologies, University of Bonn - Institute of Reconstructive Neurobiology, Kyushu University - Laboratory of Pathophysiology, Fudan University - Department of Neurosurgery, University of Zurich - Department of Molecular Life Sciences, UK Dementia Research Institute, Ohio State University (OSU) - Department of Neuroscience, Technische Universität München (TUM) - Department of Psychiatry & Psychotherapy, Sapienza University of Rome - Department of Physiology and Pharmacology, Third Rock Ventures, University of Toronto - The Hospital for Sick Children - SickKids, Mount Sinai Health System - Nash Department of Neuroscience, University of Massachusetts Worcester - Department of Neurobiology, Weizmann Institute of Science - Department of Neurobiology, German Center for Neurodegenerative Diseases (DZNE) - Institute of Neuronal Cell Biology, University of Florida - Division of Neuroscience, University of Freiburg - Faculty of Biology, Massachusetts Institute of Technology (MIT) - The Picower Institute for Learning and Memory, Celica Biomedical, Universidad San Sebastian - Faculty of Health Sciences, Nagoya University - Department of Anatomy and Molecular Cell Biology, Université Libre de Bruxelles (ULB) - Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Charité Universitätsmedizin Berlin, Mayo Clinic - Department of Neurology and Stanford University - Department of Neurology and Neurological Sciences
Downloads 992 (57,281)
Citation 18

Abstract:

Loading...

2.

Human Lungs Show Limited Permissiveness for SARS-CoV-2 Due to Scarce ACE2 Levels But Strong Virus-Induced Immune Activation in Alveolar Macrophages

Number of pages: 73 Posted: 06 Oct 2020
Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Robert Koch Institute - Unit 17 “Influenza and other Respiratory Viruses”, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Free University of Berlin (FUB) - Institut für Tierpathologie, Helmholtz Association of German Research Centres - Berlin Institute for Medical Systems Biology, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Robert Koch Institute - Unit 17 “Influenza and other Respiratory Viruses”, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Robert Koch Institute - Unit 17 “Influenza and other Respiratory Viruses”, Westfaelische Wilhelms Universität - Institute of Virology, Westfaelische Wilhelms Universität - Institute of Virology, Free University of Berlin (FUB) - Department of Veterinary Pathology, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin - Department of Nephrology, Charité - Universitätsmedizin Berlin - Department of Pathology, Chest Hospital Heckeshorn - HELIOS Clinic Emil von Behring, Chest Hospital Heckeshorn - HELIOS Clinic Emil von Behring, Klinikum Neukölln, Vivantes Clinics Neukölln - Department of Thoracic Surgery, DRK Clinics - Department for Thoracic Surgery, Charité - Universitätsmedizin Berlin - Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin - Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin - Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin - Clinic for Urology, Charité - Universitätsmedizin Berlin - Department of Pathology, Charité - Universitätsmedizin Berlin - Department of Pathology, Charité - Universitätsmedizin Berlin - Institute for Neuropathology, Charité - Universitätsmedizin Berlin - Institute for Neuropathology, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin, Helmholtz Association of German Research Centres - Berlin Institute for Medical Systems Biology, Westfaelische Wilhelms Universität - Institute of Virology, Unfallkrankenhaus Berlin - Institute of Pathology, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Free University of Berlin (FUB) - Institut für Tierpathologie, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Robert Koch Institute - Unit 17 “Influenza and other Respiratory Viruses”, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine and Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine
Downloads 213 (357,858)
Citation 4

Abstract:

Loading...

SARS-CoV-2, Covid-19, human lung, pneumonia, ARDS, alveolar macrophages, monocytes, immune activation, influenza, MERS-CoV, SARS-CoV, alveolar type II cells, autopsy, ACE2, TMPRSS2, permissiveness, lung damage, lung injury, alveolar damage, immunopathogenesis